SCHEMBL1090260

SCHEMBL1090260

O=C(c1ccccc1)N1CCCC(N2CCCC(Nc3nccc(N4CCCCCC4)n3)C2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK12 Q9NYV4 7/20 0.54
CCNK O75909 6/20 0.54
CXCR4 P61073 1/20 0.52
KDM2A Q9Y2K7 3/20 0.44
KDM6B O15054 2/20 0.44
KDM4A O75164 2/20 0.44
KDM5C P41229 2/20 0.44
KDM4C Q9H3R0 2/20 0.44
KDM3A Q9Y4C1 1/20 0.44
HRH4 Q9H3N8 3/20 0.44
KDM4E B2RXH2 2/20 0.43
POLB P06746 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK10 P53779 2/20 0.43
CCNA2 P20248 2/20 0.43
CDK2 P24941 2/20 0.43
CDK7 P50613 2/20 0.43
CCNH P51946 2/20 0.43
MNAT1 P51948 2/20 0.43
CYP3A4 P08684 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090385 0.99 CDK12 (0.53) CDK12CCNKCXCR4KDM2AKDM6B
SCHEMBL1089722 0.96 CXCR4 (0.55) CDK12CCNKCXCR4KDM2AKDM6B
SCHEMBL1090283 0.92 CXCR4 (0.53) CDK12CCNKCXCR4HRH4KDM4E
SCHEMBL1090758 0.91 CDK12 (0.57) CDK12CCNKCXCR4HRH4CCNA2
SCHEMBL1090298 0.91 CDK12 (0.55) CDK12CCNKCXCR4HRH4KDM4E
SCHEMBL1088594 0.91 CCNK (0.51) CDK12CCNKCXCR4POLBMAPK10
SCHEMBL1090064 0.91 CDK12 (0.56) CDK12CCNKCXCR4HRH4CCNA2
SCHEMBL1090868 0.91 CDK12 (0.54) CDK12CCNKCXCR4HRH4KDM4E
SCHEMBL1091241 0.90 CXCR4 (0.53) CDK12CCNKCXCR4HRH4KDM4E
SCHEMBL1089128 0.90 CCNK (0.48) CDK12CCNKCXCR4POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CDK12 2526/4885CCNK 793/4885CXCR4 1/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CDK12 2526/4885CCNK 793/4885CXCR4 1/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CDK12 2526/4885CCNK 793/4885CXCR4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.